Urticarial vasculitis after meningococcal serogroup B vaccine in a 6-year-old girl

Pediatr Dermatol. 2018 Jan;35(1):e64-e65. doi: 10.1111/pde.13339. Epub 2017 Nov 21.

Abstract

The first vaccine that shows significant potential in providing broad coverage against serogroup B meningococcal disease has recently been approved. Because of its newness, potential adverse events need to be reported. Here we report a case of urticarial vasculitis, a rare disease in children, in probable relationship with the novel vaccine.

Keywords: meningococcal B vaccine; urticarial vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Female
  • Histamine Antagonists / therapeutic use
  • Humans
  • Meningococcal Infections / prevention & control*
  • Meningococcal Vaccines / adverse effects*
  • Neisseria meningitidis, Serogroup B / immunology*
  • Skin / pathology
  • Vasculitis, Leukocytoclastic, Cutaneous / diagnosis*
  • Vasculitis, Leukocytoclastic, Cutaneous / etiology

Substances

  • Histamine Antagonists
  • Meningococcal Vaccines